Centessa Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTA and other ETFs, options, and stocks.About CNTA
Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in discovering and developing medicines that delivers transformational to patients. Its portfolio include preclinical to phase three uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases.
CEOSaurabh Saha
CEOSaurabh Saha
Employees77
Employees77
HeadquartersAltrincham, Cambridgeshire
HeadquartersAltrincham, Cambridgeshire
Founded2020
Founded2020
Employees77
Employees77
CNTA Key Statistics
Market cap3.67B
Market cap3.67B
Price-Earnings ratio-15.17
Price-Earnings ratio-15.17
Dividend yield—
Dividend yield—
Average volume3.13M
Average volume3.13M
High today$29.26
High today$29.26
Low today$27.21
Low today$27.21
Open price$27.86
Open price$27.86
Volume3.58M
Volume3.58M
52 Week high$29.26
52 Week high$29.26
52 Week low$9.60
52 Week low$9.60
Stock Snapshot
With a market cap of 3.67B, Centessa Pharmaceuticals(CNTA) trades at $28.02. The stock has a price-to-earnings ratio of -15.17.
As of 2025-11-17, Centessa Pharmaceuticals(CNTA) stock has fluctuated between $27.21 and $29.26. The current price stands at $28.02, placing the stock +3.0% above today's low and -4.2% off the high.
The Centessa Pharmaceuticals(CNTA)'s current trading volume is 3.58M, compared to an average daily volume of 3.13M.
In the last year, Centessa Pharmaceuticals(CNTA) shares hit a 52-week high of $29.26 and a 52-week low of $9.60.
In the last year, Centessa Pharmaceuticals(CNTA) shares hit a 52-week high of $29.26 and a 52-week low of $9.60.
Analyst ratings
100%
of 15 ratingsBuy
100%
Hold
0%
Sell
0%